Why Vaccine Stocks Like Moderna and Novavax Tumbled (Again) Today
Published
The bullish case for owning COVID-19 vaccine makers is weakening as much of the world throws in the towel on trying to curb the spread of the coronavirus.
Full ArticlePublished
The bullish case for owning COVID-19 vaccine makers is weakening as much of the world throws in the towel on trying to curb the spread of the coronavirus.
Full ArticleSeveral factors are dragging down these vaccine stocks.
Investors are weighing results from an Israeli study and recent comments from Moderna's CEO.